SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15,460 | -16.9% | 135 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $18,607 | +6.4% | 135 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $17,493 | +16.6% | 135 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $15,000 | +50.0% | 135 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $10,000 | -9.1% | 135 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $11,000 | -8.3% | 135 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $12,000 | -20.0% | 135 | -18.2% | 0.00% | 0.0% |
| Q3 2021 | $15,000 | +200.0% | 165 | +153.8% | 0.00% | +100.0% |
| Q2 2021 | $5,000 | 0.0% | 65 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $5,000 | -54.5% | 65 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $11,000 | +22.2% | 65 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $9,000 | -10.0% | 65 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $10,000 | +66.7% | 65 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $6,000 | -25.0% | 65 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $8,000 | – | 65 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |